FOX RUN MANAGEMENT, L.L.C.
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1533457
GREENWICH, CT
Position in AMLX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$804,913
+$377,173 QoQ
Shares Held
44,817
+26.6% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#99
of 205 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $6,581,949 across 12 Drug Manufacturers - Specialty & Generic names. AMLX ranks #3 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
29,511 | $2,120,660 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,876 | $1,020,662 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
44,817 | $804,913 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
139,728 | $688,859 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
18,952 | $466,408 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
14,556 | $293,740 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
63,112 | $283,372 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
16,028 | $277,444 |
All Filings in AMLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $804,913 | 44,817 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $427,740 | 35,409 | Shares | Sole | 2026-02-11 | |
| 2024-12-31 | $44,558 | 11,788 | Shares | Sole | 2025-02-11 | |
| 2023-12-31 | $323,943 | 22,007 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $310,995 | 16,985 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $388,087 | 17,992 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $366,691 | 12,498 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||